tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Evercore disagrees with Street reaction on Alkermes
The FlyEvercore disagrees with Street reaction on Alkermes
4h ago
TAK
ALKS
Alkermes initiated with a Buy at Truist
PremiumThe Fly
Alkermes initiated with a Buy at Truist
1d ago
TAK
ALKS
Takeda presents interim data from Phase 1b study of mezagitamab
PremiumThe Fly
Takeda presents interim data from Phase 1b study of mezagitamab
5d ago
TAK
Takeda completes seven-year Phase 3 TIDES trial of Qdenga
PremiumThe Fly
Takeda completes seven-year Phase 3 TIDES trial of Qdenga
9d ago
TAK
Takeda Pharmaceutical Reports Decline in Revenue and Profit
PremiumCompany Announcements
Takeda Pharmaceutical Reports Decline in Revenue and Profit
13d ago
Takeda Revises Financial Forecast for FY2025 Amid Strategic Shifts
PremiumCompany AnnouncementsTakeda Revises Financial Forecast for FY2025 Amid Strategic Shifts
14d ago
Takeda Pharmaceutical Reports Decline in Six-Month Financial Results, Adjusts Fiscal Year Forecasts
Premium
Company Announcements
Takeda Pharmaceutical Reports Decline in Six-Month Financial Results, Adjusts Fiscal Year Forecasts
14d ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
20d ago
BMY
NVS
Innovent Biologics announces global strategic partnership with Takeda
PremiumThe Fly
Innovent Biologics announces global strategic partnership with Takeda
22d ago
TAK
Keros Therapeutics announces share repurchase program
PremiumThe Fly
Keros Therapeutics announces share repurchase program
28d ago
TAK
KROS
Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
PremiumThe Fly
Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
1M ago
CI
GH
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
PremiumThe Fly
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
1M ago
F
AES
Takeda to discontinue cell therapy efforts
PremiumThe FlyTakeda to discontinue cell therapy efforts
1M ago
TAK
Takeda Discontinues Cell Therapy Efforts to Refocus Investments
Premium
Company Announcements
Takeda Discontinues Cell Therapy Efforts to Refocus Investments
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
BNC
CEP
Bristol Myers, Takeda, Astex to contribute data for AI tool, Reuters says
PremiumThe Fly
Bristol Myers, Takeda, Astex to contribute data for AI tool, Reuters says
1M ago
BMY
JNJ
Takeda Announces Financial Reclassification to Enhance Capital Flexibility
PremiumCompany Announcements
Takeda Announces Financial Reclassification to Enhance Capital Flexibility
2M ago
Takeda, Vela Transport announce medicine shipping partnership
PremiumThe Fly
Takeda, Vela Transport announce medicine shipping partnership
2M ago
TAK
Protagonist Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Protagonist Therapeutics initiated with an Outperform at Leerink
2M ago
JNJ
TAK
Alkermes price target lowered to $43 from $45 at Needham
PremiumThe FlyAlkermes price target lowered to $43 from $45 at Needham
2M ago
TAK
ALKS
Harmony Biosciences price target lowered to $48 from $49 at Needham
Premium
The Fly
Harmony Biosciences price target lowered to $48 from $49 at Needham
2M ago
TAK
HRMY
Alkermes price target raised to $35 from $34 at JPMorgan
Premium
The Fly
Alkermes price target raised to $35 from $34 at JPMorgan
2M ago
TAK
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >